We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:MAZE
​
​
logo

Maze Therapeutics (MAZE)

Nasdaq • MAZE • US5787841007

34.91Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 26, 2026, ORTEX estimated 21.2% of free float sold short, 9.2 days to cover, cost to borrow 0.5%. Sign up for live short interest data.

Market Cap

1.88b USD | # 4013 in US

Volume

674.74k shares | 18.94m USD

Shares Outstanding

53.93m

Free Float Shares

65.29% | 35.21m

News

MAZE key data

Maze Therapeutics (Nasdaq: MAZE) has a market capitalization of $1.88B. Last close $34.91 (as of 2026-11-10); 52-week range $21.95 to $53.65. ORTEX data as of 2026-10-26: short interest was 21.22% of free float, 9.2 days to cover and the average cost to borrow was 0.5%. Sign up for live short interest data.

Latest on MAZE

  • May 13, 2026Maze Therapeutics Heads Into Q1 Print With Short Interest at a Six-Week High
All MAZE news on ORTEX News
  • MAZE news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.